Cofetuzumab Pelidotin

Cofetuzumab Pelidotin
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82930-1 1 mg - - -

3 - 8 business days*

1,594.00€
BPS-82930-2 5 mg - - -

3 - 8 business days*

3,813.00€
BPS-82930-3 10 mg - - -

3 - 8 business days*

5,773.00€
 
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb... more
Product information "Cofetuzumab Pelidotin"
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research1,2,3.
Keywords: Anti-PTK7, Anti-CCK4, Anti-CCK-4, Anti-Colon carcinoma kinase 4, Anti-Protein-tyrosine kinase 7, Anti-Tyrosine-protein kinase-like 7, Anti-Pseudo tyrosine kinase receptor 7, Anti-Inactive tyrosine-protein kinase 7,
Supplier: BPS Bioscience
Supplier-Nr: 82930

Properties

Application: Cancer therapy target studies
Conjugate: No
Species reactivity: human
Format: Solution

Database Information

CAS : 1869937-48-3| Matching products
KEGG ID : K05127 | Matching products
UniProt ID : Q13308 | Matching products
Gene ID : GeneID 5754 | Matching products

Handling & Safety

Storage: -80°C (protect from light)
Shipping: -80°C (International: -80°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Cofetuzumab Pelidotin"
Write a review
or to review a product.
Viewed